Sai Parenteral's IPO Day 3: Check GMP, subscription status, and more - Should you apply on the final day?

-30.2

Market Impact Score

-100 Bearish+100 Bullish

AI Analysis

Weak IPO subscriptions can signal a lack of investor confidence or concerns about valuation in the primary market.

Bearish bias for IPO listings with low subscription; consider avoiding or shorting if possible post-listing.

Quick check: TATASTEEL bullish bias (+2.7% 1d), HINDALCO bearish bias (+1.9% 1d).

•Sai Parenteral’s IPO subscribed only 0.42 times by Day 2.
•The IPO is for ₹409 crore, including a fresh issue and an offer for sale.
•Analysts are divided on the company's long-term potential versus current valuations.
•Risk flag: Low investor demand
•Risk flag: Potential for weak listing performance

Sectors:metals

AI-powered analysis by